18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
Nikhil Joshi(University of Edinburgh), David E. Newby(University of Edinburgh), William Wallace(University of Edinburgh), Nicholas L. Mills(University of Edinburgh), Michelle C. Williams(University of Edinburgh), Donald M. Salter(Edinburgh Cancer Research), Keith A.A. Fox(University of Edinburgh), Patrick A. Calvert(University of Cambridge), Marc R. Dweck(University of Edinburgh), Felicity Craighead(University of Edinburgh), Alex Vesey(University of Edinburgh), Anoop Shah(Imperial College Healthcare NHS Trust), Andrew D. Flapan(Edinburgh Royal Infirmary), James H.F. Rudd(University of Cambridge), Edwin J.R. van Beek(University of Edinburgh), Nicholas L. Cruden(Edinburgh Royal Infirmary), Neal Uren(Edinburgh Royal Infirmary), Su Ern Yeoh(Evolved Analytics (United States)), Miles Behan(Edinburgh Royal Infirmary), Alison Fletcher(University of Edinburgh)
Cited by 942
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2011|1.9k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
|New England Journal of Medicine|2012|941
Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure
|Particle and Fibre Toxicology|2005|929